Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / EIT Pharma

EIT Pharma

Series AUS
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$35.0Msum of rounds with a disclosed amount only
Named investors
3
Financing history
1 rounds
  1. Aug 31, 2026
    Series A · $35.0M (disclosed)
    Good Ventures (participant)Propel Bio Management, LLC (lead) via Richard KayneArrowtown (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “EIT Pharma Closes Oversubscribed $35 Million Series A Round, Led by Propel Bio Partners”
Investors on record
3 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Aug 31, 2026
    EIT Pharma announced Series A of $35,000,000, led by Propel Bio Partners
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company